1. Aspirin

   Case report 30 March 2024 Pages: 51 - 51

2. Aspirin/Warfarin

   Case report 30 March 2024 Pages: 52 - 52

3. Atezolizumab/nivolumab

   Case report 30 March 2024 Pages: 53 - 53

4. Atorvastatin

   Case report 30 March 2024 Pages: 54 - 54

5. Avelumab

   Case report 30 March 2024 Pages: 55 - 55

6. Azacitidine

   Case report 30 March 2024 Pages: 56 - 56

7. Azacitidine

   Case report 30 March 2024 Pages: 57 - 57

8. Azacitidine

   Case report 30 March 2024 Pages: 58 - 58

9. Azacitidine/cyclophosphamide/melphalan

   Case report 30 March 2024 Pages: 59 - 59

10. Azacitidine/Deferiprone

    Case report 30 March 2024 Pages: 60 - 60

11. Azathioprine

    Case report 30 March 2024 Pages: 61 - 61

12. Azathioprine/Efgartigimod-alfa/Prednisone

    Case report 30 March 2024 Pages: 62 - 62

13. Azathioprine/vedolizumab

    Case report 30 March 2024 Pages: 63 - 63

14. AZD-1222/Ad26.COV2-S/tozinameran

    Case report 30 March 2024 Pages: 64 - 64

15. AZD-1222/tozinameran

    Case report 30 March 2024 Pages: 65 - 65

16. Azithromycin

    Case report 30 March 2024 Pages: 66 - 66

17. BCG

    Case report 30 March 2024 Pages: 67 - 67

18. BCG-vaccine

    Case report 30 March 2024 Pages: 68 - 68

19. Belimumab/tozinameran

    Case report 30 March 2024 Pages: 69 - 69

20. Benzylpenicillin

    Case report 30 March 2024 Pages: 70 - 70

21. Bepridil/edoxaban/olmesartan-medoxomil

    Case report 30 March 2024 Pages: 71 - 71

22. Bevacizumab

    Case report 30 March 2024 Pages: 72 - 72

23. Bivalirudin/Heparin/Warfarin

    Case report 30 March 2024 Pages: 73 - 73

24. Bleomycin

    Case report 30 March 2024 Pages: 74 - 74

25. Bortezomib/daratumumab/lenalidomide

    Case report 30 March 2024 Pages: 75 - 75

26. Botulinum-antitoxin

    Case report 30 March 2024 Pages: 76 - 76

27. Brexucabtagene-autoleucel/dasatinib

    Case report 30 March 2024 Pages: 77 - 77

28. Brolucizumab

    Case report 30 March 2024 Pages: 78 - 78

29. Buspirone/Citalopram/Nabilone

    Case report 30 March 2024 Pages: 79 - 79

30. Caffeine/sodium-benzoate abuse

    Case report 30 March 2024 Pages: 80 - 80

31. Canakinumab

    Case report 30 March 2024 Pages: 81 - 81

32. Candesartan-cilexetil

    Case report 30 March 2024 Pages: 82 - 82

33. Candida-antigen

    Case report 30 March 2024 Pages: 83 - 83

34. Caplacizumab/glucocorticoids/rituximab

    Case report 30 March 2024 Pages: 84 - 84

35. Catequentinib

    Case report 30 March 2024 Pages: 85 - 85

36. Catequentinib

    Case report 30 March 2024 Pages: 86 - 86

37. Cefotaxime

    Case report 30 March 2024 Pages: 87 - 87

38. Cemiplimab

    Case report 30 March 2024 Pages: 88 - 88

39. Cemiplimab

    Case report 30 March 2024 Pages: 89 - 89

40. Cemiplimab/Pembrolizumab

    Case report 30 March 2024 Pages: 90 - 90

41. Ciclosporin/Posaconazole

    Case report 30 March 2024 Pages: 91 - 91

42. Cilgavimab/tixagevimab

    Case report 30 March 2024 Pages: 92 - 92

43. Cinacalcet/vitamin-D

    Case report 30 March 2024 Pages: 93 - 93

44. Ciprofloxacin/nitrofurantoin

    Case report 30 March 2024 Pages: 94 - 94

45. Cisplatin

    Case report 30 March 2024 Pages: 95 - 95

46. Cisplatin/doxorubicin/ifosfamide

    Case report 30 March 2024 Pages: 96 - 96

47. Cisplatin/Paclitaxel

    Case report 30 March 2024 Pages: 97 - 97

48. Cisplatin/paclitaxel/tislelizumab

    Case report 30 March 2024 Pages: 98 - 98

49. Clofazimine/dapsone

    Case report 30 March 2024 Pages: 99 - 99

50. Clozapine

    Case report 30 March 2024 Pages: 100 - 100